Pro-inflammatory cytokine release pathways

Pro-inflammatory cytokine release pathways represent a broad category of intracellular signaling networks and molecular processes responsible for the production and secretion of inflammatory mediators such as TNF-α, IL-1β, and IL-6. These pathways, including NF-κB, MAPK, and JAK-STAT, are triggered by pattern recognition receptors (PRRs) or cytokine receptors in response to pathogens or cellular stress (StatPearls: NF-kappa B Signaling Pathway, 2023). While vital for host defense and wound healing, chronic or excessive activation of these pathways drives the pathogenesis of numerous inflammatory and autoimmune disorders, including rheumatoid arthritis and Crohn's disease (Nature Reviews Immunology: Cytokine targets in inflammation, 2021). Pharmacological intervention typically targets specific nodes within these pathways, such as individual cytokines or their associated kinases, to restore immune homeostasis (PubMed: Targeting cytokine signaling, 2022). However, because these pathways are integral to normal immune surveillance, their inhibition can lead to significant safety concerns, most notably an increased susceptibility to opportunistic infections (NIH: Risks of Immunosuppressive Therapy, 2023). Consequently, therapeutic development focuses on achieving high specificity to minimize off-target effects while effectively dampening the inflammatory cascade.

Other names

Inflammatory signaling pathwaysCytokine production pathwaysPro-inflammatory signaling cascadesCytokine secretion pathways

Inhibition of specific cytokine ligands, blockade of cytokine receptors, or modulation of intracellular signaling transducers (e.g., JAKs, MAPKs) and transcription factors (e.g., NF-κB) to prevent the synthesis and release of inflammatory mediators.